Investing Profile

Alexander Mayweg

InvestorVC
Managing Director at Versant Ventures
Photo of Alexander Mayweg, Managing Director at Versant Ventures

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Versant Ventures Managing Director
$100K - $5.0M
$1.5M
16
$102.2M
CompanyStageDateRound SizeTotal Raised
Bright Peak Therapeutics
Series CJun 2024$90M
Series BJun 2021$110M
Series AJul 2020$35M
$230M
Co-investors: Tom Woiwode (Versant Ventures), Josh Resnick
SixPeaks Bio
Series AMay 2024$30M
$30M
Launchpad Therapeutics
Series ADec 2022$30M
$30M
Co-investors: Ali Behbahani (New Enterprise Associates (NEA))
Vector BioPharma
Series AAug 2022$30M
$30M
Cimeio Therapeutics
Series AApr 2022$50M
$50M
T-knife
Series BAug 2021$110M
Series AAug 2020$78M
$200M
Co-investors: Olivier Litzka (Andera Partners)
Monte Rosa Therapeutics
Series CMar 2021$95M
Series BSep 2020$96M
Series AMay 2020$33M
$220M
Co-investors: Ali Behbahani (New Enterprise Associates (NEA)), Andrew Schiff (Aisling Capital), Markus Warmuth (Versant Ventures)
Matterhorn Biosciences
Series UnknownAug 2020$30M
$30M